Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Implementation Research on Coordinated Combinations of Community-Clinical Linkage Strategies for Diabetes Prevention and Management

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Centers For Disease Control And PreventionView Agency

NAICS

N/A

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 28

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Centers For Disease Control And Prevention

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Health And Human Services → Centers For Disease Control And Prevention

View Agency Profile

Office AddressUS

Contacts

Natalie Brown

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

Diabetes causes illness and death in the United States. It leads to high health care costs. People who use Federally Qualified Health Centers (FQHCs) and other safety-net clinics face greater risks. Many community-clinical linkage (CCL) strategies show benefits when used alone. We know less about how several strategies can be combined and coordinated. Using multiple strategies together may improve diabetes prevention and management in primary care.

This NOFO aims to find what helps or blocks the use of coordinated CCL strategies. We will identify factors that affect adoption, integration, and long-term success. Researchers will study real-world FHQC clinics. Practical evidence will guide best practices for diabetes prevention and management.

More opportunities from Department Of Health And Human Services → Centers For Disease Control And Prevention

Same awarding agency

Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE NetworkThe Centers for Disease Control and Prevention is seeking applicants to sustain and expand the US Influenza Vaccine Effectiveness Network, which aims to generate critical data on the effectiveness of influenza and other respiratory pathogen vaccines across all age groups. The initiative requires proposing work under four interconnected components: annual vaccine effectiveness and correlates of protection surveillance through active outpatient enrollment and systematic pathogen testing; electronic surveillance for acute respiratory illness and vaccine effectiveness; household transmission research; and immunogenicity studies. Applicants must apply for either Component A or Component B, but not both, with the option to add Component C or D as supplementary proposals. Component A focuses on direct surveillance and is anticipated to fund up to five sites at $1,800,000 annually, while Component B supports coordination and surge capacity with one site funded at the same level. Optional Component C, focused on household transmission, may be awarded to up to two Component A sites at $100,000 annually, and optional Component D for immunogenicity research may be granted to up to three sites from either Component A or B at $750,000 annually. The opportunity is open through a forecasted notice issued by the Department of Health and Human Services, with point of contact information provided for inquiries.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Expanded Surveillance for Pediatric Infectious DiseasesThe Centers for Disease Control and Prevention is seeking U.S. institutions to establish a national network for standardized, active surveillance of pediatric acute respiratory illness and acute gastroenteritis in healthcare settings. The core requirement involves monitoring pediatric patients in inpatient and emergency department environments for these conditions, following CDC-established protocols, and using molecular assays to confirm viral causes. The primary goal is to generate reliable estimates of the effectiveness of existing prevention tools such as vaccines for influenza, rotavirus, and respiratory syncytial virus, while also capturing data on hospitalization rates and disease progression. Institutions may optionally extend surveillance to outpatient clinics and conduct additional research on immune responses to infection and immunization. Data collected will directly inform public health strategies, improve clinical diagnosis and treatment guidelines, and support evidence-based recommendations for prevention products. The initiative aims to reduce the burden of viral illnesses on children and the healthcare system by enhancing understanding of disease patterns and intervention impacts. The funding opportunity, titled Expanded Surveillance for Pediatric Infectious Diseases, was posted on July 28, 2026, with applications managed through CDC and directed to Jamal Bankhead at the Department of Health and Human Services.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

NIOSH Centers of Excellence for Total Worker Health® (U19)

POSTED

DEADLINE

Health Promotion and Disease Prevention Research Centers: 2027 Special Interest Project Supplements (SIPS)The Centers for Disease Control and Prevention, under the Department of Health and Human Services, is offering supplemental funding to its twenty existing Prevention Research Centers to support Special Interest Projects aimed at advancing public health practice through applied research in real-world settings. These projects are designed to identify, test, evaluate, and translate evidence-based interventions that prevent and reduce the leading causes of illness, disability, and death in the United States. The funding will enable the centers to carry out ten targeted initiatives focusing on areas such as cancer survivorship care planning, leveraging Medicare and cancer registry data to improve clinical care and trial enrollment, developing community-based messaging to reduce alcohol use for cancer prevention, enhancing access to gynecologic oncologists for ovarian cancer patients, creating visual tools for sunscreen application, building emergency preparedness plans linked to weather events, establishing frameworks for prostate cancer care and support services, advancing public health strategies for hereditary cancer, and exploring emerging issues in chronic disease prevention and care. Applications are open to the current network of CDC Prevention Research Centers, with no set-aside or specific eligibility criteria beyond existing funding status. The opportunity was posted on July 28, 2026, and inquiries should be directed to Natalie Darling, MPH, Scientific Program Official, at researchnofo@cdc.gov or 770-488-5740. The projects are expected to produce actionable findings that inform policy, improve clinical and community-based practices, and ultimately contribute to reducing the burden of preventable diseases across the nation. No NAICS code or place of performance is specified, indicating that work may be conducted across the centers’ existing geographic and institutional networks.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

NIOSH Exploratory/Developmental Grant Program (R21)The NIOSH Exploratory/Developmental Grant Program (R21) aims to drive innovative research that advances the understanding and prevention of occupational diseases and injuries by identifying workplace risk factors, developing practical strategies to reduce exposure to hazards, and translating scientific findings into tangible prevention tools and interventions. The program prioritizes high-impact, early-stage research that introduces novel scientific concepts, new model systems, or transformative technologies capable of significantly improving occupational safety and health outcomes. Applicants are expected to clearly articulate the specific occupational health burden their project targets, demonstrate how their proposed activities will generate direct outputs to alleviate that burden, and outline both immediate and long-term impacts of their research. Funded by the Centers for Disease Control and Prevention under the Department of Health and Human Services, this opportunity is open to researchers seeking support for exploratory and developmental investigations with strong potential for future scalability and real-world application. The grant is administered through NIOSH, with Bridgette Garrett, PhD, serving as the primary scientific program official for inquiries. The funding opportunity was posted on July 27, 2026, and detailed application information is available through the Grants.gov portal, though specific set-asides, NAICS codes, or location restrictions are not designated. Proposals must align with the program’s three core objectives and provide a compelling case for innovation and potential public health impact in the realm of workplace safety.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Early Detection, Response, and Control of Global Rabies Outbreaks and Associated Threats to America's Dog-Rabies Free StatusThis funding opportunity supports research aimed at developing and implementing technology-driven, cost-effective tools to reduce the global burden of human rabies and advance progress toward eliminating canine rabies, particularly in high-burden countries. Key research priorities include electronic systems for tracking vaccinations in humans and dogs, improving the management of human rabies exposure investigations, strengthening laboratory information systems for rabies, modeling the economic impact of dog-mediated rabies interventions, and estimating populations of rabies-susceptible dogs. The goal is to generate data-driven strategies that enhance surveillance, response, and control capabilities to protect public health and prevent the re-emergence of rabies in regions like the United States, which currently maintains a dog-rabies-free status. The notice, issued by the Centers for Disease Control and Prevention under the Department of Health and Human Services, is posted with a forecast date of July 27, 2026, and is open to applicants focused on global rabies control. Point of contact for inquiries is Robert Brian York, reachable via email or phone, and additional information is available through the grants.gov portal. While no specific set-aside or NAICS code is provided, the initiative is aligned with public health objectives to prevent rabies transmission and support international efforts toward eradication by leveraging innovative, scalable technologies.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support ToolsThe Centers for Disease Control and Prevention is seeking proposals to pilot test, implement, and evaluate clinical decision support tools for cervical, breast, and colorectal cancer screening and management. The initiative targets large health systems and aims to integrate computable, evidence-based guidelines directly into electronic health record systems to improve clinician decision-making at the point of care. Component A focuses on full-scale implementation and rigorous evaluation of an existing cervical cancer CDS tool, with emphasis on increasing guideline-concordant screening and ensuring timely follow-up after abnormal results. Component B involves the technical integration and empirical evaluation of interoperable CDS tools for breast and colorectal cancer, requiring documentation of the implementation process and measurement of tool accuracy and real-world impact. Both components build on previously developed CDC algorithms and require applicants to demonstrate robust assessment methods for effectiveness and adoption within operational healthcare environments. Proposals must align with CDC’s goal of advancing equitable, data-driven cancer prevention strategies across diverse clinical settings.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

NIOSH Small Research Grant Program (R03)The NIOSH Small Research Grant Program (R03) is designed to advance occupational safety and health by supporting research that identifies risks and conditions leading to work-related diseases and injuries, explores strategies to reduce those risks, and translates scientific discoveries into practical prevention tools and practices. This grant mechanism is intended for projects that can be completed with limited resources, such as pilot studies, feasibility assessments, secondary data analysis, or the development of new research methodologies, making it accessible for early-stage or resource-constrained investigators. Applicants are required to clearly define the occupational health problem they aim to address and explicitly connect their proposed activities to measurable outputs that will reduce the burden of work-related illness and injury, both during the grant period and in the long term. Funded by the Centers for Disease Control and Prevention under the Department of Health and Human Services, the program is open to researchers seeking to generate actionable insights that can inform workplace safety practices. The solicitation is currently forecasted for a July 2026 posting, with no set-aside type or NAICS code specified. The point of contact for inquiries is Jessica M.K. Streit, PhD, CHES, Scientific Program Official, reachable via email at jstreit@cdc.gov or phone at 513-533-8107. While the place of performance and organization type are not defined, the grant supports research activities that must be grounded in real-world occupational health challenges and must demonstrate potential for tangible impact beyond the academic setting.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)The NIOSH Support for Conferences and Scientific Meetings (U13) program is designed to fund high-quality scientific gatherings that advance occupational safety and health research in alignment with NIOSH’s strategic priorities. These events may include conferences, symposia, workshops, or seminars, whether held in person or virtually, and must focus on exchanging knowledge, coordinating efforts, or clarifying key issues in the field. The program explicitly excludes training-only events and requires that proposed meetings contribute meaningfully to research objectives central to NIOSH’s mission. This cooperative agreement mechanism allows for substantial federal involvement, with NIOSH staff potentially assisting in planning, coordinating, and participating in activities before and after the award. The opportunity is posted under the Centers for Disease Control and Prevention, part of the Department of Health and Human Services, with no set-aside or NAICS code specified. Prospective applicants can direct inquiries to Sharon Chiou, PhD, the Scientific Program Official, via email or phone. The forecast dates to July 22, 2026, indicating an anticipated release timeline for formal applications, though the solicitation number is not yet available. The place of performance is not restricted to a specific location, allowing for flexibility in meeting venues, and all proposed activities must remain within the scope of public health research relevant to worker safety and health.

Convention and Trade Show Organizers

POSTED

DEADLINE

Occupational Safety and Health Research (R01)The R01 grant program administered by the Centers for Disease Control and Prevention under the Department of Health and Human Services aims to advance occupational safety and health research by supporting discrete, investigator-initiated projects that address critical risks and conditions linked to work-related diseases and injuries. The program prioritizes research that enhances understanding of workplace hazards, evaluates effective methods to reduce exposure, and translates scientific discoveries into practical prevention strategies, interventions, or products designed to reduce occupational illness and injury. Applicants are required to clearly articulate the occupational health issue their project targets and demonstrate how the proposed research will generate tangible outputs capable of making a measurable impact during the project timeline and beyond. The funding opportunity is open to researchers whose work aligns with the mission of NIOSH, emphasizing scientific rigor and real-world applicability. Prospective grantees must outline the expected outcomes and long-term benefits of their research, ensuring that findings contribute meaningfully to improving worker health and safety. The solicitation, posted on July 22, 2026, carries no set-aside designation and is accessible through the Grants.gov portal. For inquiries, applicants may contact Sharon Chiou, PhD, Scientific Program Official, via email at schiou@cdc.gov or by phone at 304-285-6029. The project’s performance location and organizational details are not specified, reflecting its national scope and flexibility in execution.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)The NIOSH Support for Conferences and Scientific Meetings program, designated as R13 and not allowing clinical trials, aims to fund high-quality gatherings that advance occupational safety and health research in alignment with NIOSH’s mission. These events may include conferences, symposia, seminars, or workshops where participants exchange information and collaborate on critical topics, provided they are not training-only activities. The program emphasizes scientific rigor and relevance to current NIOSH priorities, ensuring that funded meetings contribute meaningfully to the field of workplace health and safety. Applications must demonstrate clear objectives, alignment with NIOSH goals, and the potential to foster collaboration among researchers, practitioners, and stakeholders. The opportunity is forecasted by the Centers for Disease Control and Prevention under the U.S. Department of Health and Human Services, with no set-aside designation or NAICS code specified. The primary point of contact for inquiries is Sharon Chiou, PhD, Scientific Program Official, reachable via email at schiou@cdc.gov or phone at 304-285-6029. The solicitation was posted on July 22, 2026, and further details can be found through the grants.gov portal at the provided link. While the physical location of performance is not specified, events may be held either in person or virtually, and applicants are expected to propose meetings that maximize impact within the occupational safety and health community.

Convention and Trade Show Organizers

POSTED

DEADLINE

NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)This contract, titled NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60), aims to fund applied research that develops field-ready automation, robotics, and intelligent systems to enhance safety and health in U.S. mining operations. Despite a historic low in injury rates, persistent risks remain in emergency communication, self-escape under low-visibility conditions, and refuge performance, especially with ongoing incidents involving powered-haulage, machinery, roof and rib failures, and pressure-vessel events. The initiative seeks technologies that ensure assured autonomy—systems that operate safely without compromising productivity—by improving situational awareness through advanced sensors, AI, data fusion, and decision-support tools. Research must focus on practical implementation, including human-centered design, training protocols, safety evaluation methods, and technologies for miner-rescue and post-disaster surveillance. Eligibility is strictly limited to U.S. academic institutions that offer both an ABET-accredited undergraduate program in mining or mineral engineering and graduate programs in both mining engineering and explosives engineering. Applicants are expected to align their proposals with the Miner Health Program’s 2020–2030 Strategic Agenda and must clearly articulate specific goals tied to documented safety burdens, supported by data on mortality, morbidity, and at-risk populations. Leveraging existing mining and explosives-engineering research facilities is encouraged, and proposals must demonstrate how their solutions will reduce hazardous exposures and improve overall miner well-being. The funding opportunity is administered by the Centers for Disease Control and Prevention through the Department of Health and Human Services, with point of contact Maria Lioce, MD, overseeing scientific program direction.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE